Recursion Pharmaceuticals Inc (RXRX)
6.40
+0.08
(+1.27%)
USD |
NASDAQ |
Nov 01, 16:00
6.405
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Gross Profit Margin (Quarterly): 36.14% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 36.14% |
| March 31, 2024 | 17.23% |
| December 31, 2023 | 6.99% |
| September 30, 2023 | -7.67% |
| June 30, 2023 | 14.83% |
| Date | Value |
|---|---|
| March 31, 2023 | -2.59% |
| December 31, 2022 | 20.74% |
| September 30, 2022 | -18.05% |
| June 30, 2022 | -85.90% |
| March 31, 2022 | -47.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-85.90%
Minimum
Jun 2022
36.14%
Maximum
Jun 2024
-6.55%
Average
2.20%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Pfizer Inc | 70.27% |
| Revance Therapeutics Inc | 73.03% |
| Twist Bioscience Corp | 43.30% |
| NovaBay Pharmaceuticals Inc | 66.33% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.57% |
| Return on Assets | -57.07% |
| Return on Invested Capital | -78.34% |
| Profit Margin (Quarterly) | -677.2% |
| Operating Margin (Quarterly) | -698.0% |
| Return on Net Operating Assets | -167.8% |